Trial · NCT02092467
Results by group1,010
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 1,010
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Incidence Rate of Adjudicated Malignancies Excluding Non-melanoma Skin Cancers (NMSC) | Tofacitinib 5 mg BID | 1.13 | 95% Confidence Interval 0.87 to 1.45 | participants with event/100 PY | |
| Incidence Rate of Adjudicated Malignancies Excluding Non-melanoma Skin Cancers (NMSC) | Tofacitinib 10 mg BID | 1.13 | 95% Confidence Interval 0.86 to 1.45 | participants with event/100 PY | |
| Incidence Rate of Adjudicated Malignancies Excluding Non-melanoma Skin Cancers (NMSC) | All Tofacitinib | 1.13 | 95% Confidence Interval 0.94 to 1.35 | participants with event/100 PY | |
| Incidence Rate of Adjudicated Malignancies Excluding Non-melanoma Skin Cancers (NMSC) | TNFi | 0.77 | 95% Confidence Interval 0.55 to 1.04 | participants with event/100 PY | |
| Incidence Rate of Adjudicated Major Adverse Cardiovascular Events (MACE) | Tofacitinib 5 mg BID | 0.91 | 95% Confidence Interval 0.67 to 1.21 | participants with event/100 PY | |
| Incidence Rate of Adjudicated Major Adverse Cardiovascular Events (MACE) | Tofacitinib 10 mg BID | 1.05 | 95% Confidence Interval 0.78 to 1.38 | participants with event/100 PY | |
| Incidence Rate of Adjudicated Major Adverse Cardiovascular Events (MACE) | All Tofacitinib | 0.98 | 95% Confidence Interval 0.79 to 1.19 | participants with event/100 PY | |
| Incidence Rate of Adjudicated Major Adverse Cardiovascular Events (MACE) | TNFi | 0.73 | 95% Confidence Interval 0.52 to 1.01 | participants with event/100 PY | |
| Incidence Rate of Non-fatal Stroke | Tofacitinib 5 mg BID | 0.27 | 95% Confidence Interval 0.15 to 0.45 | participants with event/100 PY | |
| Incidence Rate of Non-fatal Stroke | Tofacitinib 10 mg BID | 0.33 | 95% Confidence Interval 0.19 to 0.53 | participants with event/100 PY | |
| Incidence Rate of Non-fatal Stroke | TNFi | 0.34 | 95% Confidence Interval 0.20 to 0.54 | participants with event/100 PY | |
| Incidence Rate of Non-fatal Myocardial Infarction | Tofacitinib 5 mg BID | 0.37 | 95% Confidence Interval 0.22 to 0.57 | participants with event/100 PY | |
| Incidence Rate of Non-fatal Myocardial Infarction | Tofacitinib 10 mg BID | 0.33 | 95% Confidence Interval 0.19 to 0.53 | participants with event/100 PY | |
| Incidence Rate of Non-fatal Myocardial Infarction | TNFi | 0.16 | 95% Confidence Interval 0.07 to 0.31 | participants with event/100 PY | |
| Incidence Rate of Adjudicated Opportunistic Infection Events Including Tuberculosis | Tofacitinib 5 mg BID | 0.76 | 95% Confidence Interval 0.54 to 1.04 | participants with event/100 PY | |
| Incidence Rate of Adjudicated Opportunistic Infection Events Including Tuberculosis | Tofacitinib 10 mg BID | 0.91 | 95% Confidence Interval 0.66 to 1.22 | participants with event/100 PY | |
| Incidence Rate of Adjudicated Opportunistic Infection Events Including Tuberculosis | TNFi | 0.42 | 95% Confidence Interval 0.26 to 0.64 | participants with event/100 PY | |
| Incidence Rate of Adjudicated Hepatic Events | Tofacitinib 5 mg BID | 0.90 | 95% Confidence Interval 0.66 to 1.20 | participants with event/100 PY | |
| Incidence Rate of Adjudicated Hepatic Events | Tofacitinib 10 mg BID | 1.51 | 95% Confidence Interval 1.18 to 1.91 | participants with event/100 PY | |
| Incidence Rate of Adjudicated Hepatic Events | TNFi | 0.70 | 95% Confidence Interval 0.49 to 0.97 | participants with event/100 PY |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02092467/results